Trademark Overview
On Wednesday, November 19, 2025, a trademark application was filed for PRIMEBODY with the United States Patent and Trademark Office. The USPTO has given the PRIMEBODY trademark a serial number of 99503974. The federal status of this trademark filing is NEW APPLICATION - RECORD INITIALIZED NOT ASSIGNED TO EXAMINER as of Wednesday, November 19, 2025. This trademark is owned by Voro Therapeutics, Inc.. The PRIMEBODY trademark is filed in the Pharmaceutical Products and Computer & Software Services & Scientific Services categories with the following description:
Pharmaceutical preparations for the treatment of cancer, immune-related, autoimmune, metabolic, and inflammatory diseases; therapeutic pharmaceuticals for the treatment of cancer, immune-related, autoimmune, metabolic, and inflammatory diseases; pharmaceutical preparations, namely, pro drug or drug delivery systems comprising biologics for conditional activation, tissue or tumor targeting; therapeutic and diagnostic agents, preparations, and substances for medical purposes; pharmaceutical preparations and substances for use in the field of oncology, immunology, autoimmune, metabolic, and inflammatory diseases; therapeutic and diagnostic agents and preparations consisting primarily of biochemicals for medical use
Scientific and technological research and development in the fields of pharmaceuticals, biotechnology, and medical diagnostics namely, preparations, biologics, and diagnostic agents; development of drugs for oncology, immunology, autoimmune, metabolic, and inflammatory diseases, conditionally-activated or tumor-activated therapeutics or biologics; providing a scientific and technological platform for research and development of drug candidates; conducting clinical and pre-clinical research in the field of pharmaceuticals and biotechnology; pharmaceutical research, development, and analysis, namely relating to the treatment of cancer, immune-related, autoimmune, metabolic, and inflammatory diseases; providing scientific information and data relating to pharmaceutical, biotechnological, and clinical research